Bioqual (Bioqual) YoY EBITDA Growth : -15.37% (As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bioqual's YoY EBITDA Growth for the quarter that ended in May. 2018 was -15.37%.

Bioqual's EBITDA per Share for the six months ended in May. 2018 was $6.81.

Bioqual YoY EBITDA Growth Historical Data

The historical data trend for Bioqual's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual YoY EBITDA Growth Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

YoY EBITDA Growth

Get a 7-Day Free Trial

26.61

-37.51

0.73

385.57

-15.37

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
YoY EBITDA Growth	Get a 7-Day Free Trial										26.61	-37.51	0.73	385.57	-15.37

Bioqual YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bioqual's YoY EBITDA Growth for the fiscal year that ended in May. 2018 is calculated as:

	YoY EBITDA Growth (A: May. 2018 )
=	(EBITDA per Share (A: May. 2018 )	-	EBITDA per Share (A: May. 2017 ))	/	\| EBITDA per Share (A: May. 2017 ) \|
=	(6.805	-	8.041)	/	\| 8.041 \|
=	-15.37 %

Bioqual's YoY EBITDA Growth for the quarter that ended in May. 2018 is calculated as:

	YoY EBITDA Growth (Q: May. 2018 )
=	(EBITDA per Share (Q: May. 2018 )	-	EBITDA per Share (Q: May. 2017 ))	/	\| EBITDA per Share (Q: May. 2017 ) \|
=	(6.805	-	8.041)	/	\| 8.041 \|
=	-15.37 %

Bioqual YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Bioqual's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » YoY EBITDA Growth

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines